SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Vera Therapeutics, Inc. is a clinical stage biotechnical company, which engages in the development and commercialization of transformative treatments for immunological diseases. Its product includes the TRUTAKNA injection. The company was founded by Marshall W. Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is trending following the announcement of final efficacy analysis results from the Phase 3 ORIGIN 3 trial, which demonstrated significant preservation of renal function and reduced disease progression in patients with IgA nephropathy. The community is highlighting the potential for a full FDA approval and the company's strong position in the IgA nephropathy market, although some discourse remains focused on short-term price action and the impact of the drug's existing accelerated approval status.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending following the official completion of a major at-the-market share offering and the successful funding of its planned Iridium acquisition, a development that investors note removes a significant financing risk. Community reaction is mixed, with bulls viewing the de-risked balance sheet as a catalyst for future growth, while some traders remain skeptical due to broader market volatility and concerns over long-term profitability.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgent Power Solutions is attracting attention following record fiscal fourth-quarter results, characterized by significant growth in revenue, bookings, and a record backlog. Investors remain highly bullish on the company's FY27 guidance and expansion plans, though some traders express caution regarding the potential impact of share offerings on the stock's near-term performance.

Dave & Buster's Entertainment, Inc. engages in the ownership and operation of entertainment and dining venues under the name Dave & Buster's. It offers a full menu of entrées and appetizers, a selection of alcoholic and non-alcoholic beverages, and an assortment of entertainment attractions centered around playing games and watching live sports and other televised events. The company was founded by David O. Corriveau and James W. Corley in 1982 and is headquartered in Coppell, TX.

Dave & Buster`s Entertainment Inc

Dave & Buster's Entertainment

Dave & Buster's shares dropped following a second-quarter earnings miss where revenue and earnings fell short of analyst expectations, leading to a wave of price target cuts from multiple analysts. While the community remains divided between those concerned about the company's long-term debt and turnaround efforts and retail traders who remain optimistic about management's "Back-to-Basics" strategy, the primary driver is the disappointing financial performance.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Churchill Capital Corp XI - Ordinary Shares - Class A

Churchill Capital Corp XI is trending due to significant investor attention following the announced merger with Agility Robotics, a company developing humanoid robots for industrial use. Traders are closely monitoring the deal as a pure-play opportunity in physical AI, noting the company's backing from major tech firms and ongoing warehouse deployments, while debating the volatility typical of SPAC structures.

Aeluma, Inc. engages in developing semiconductors for sensing, communication, and computing applications. The firm is also involved in manufacturing devices using compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass market microelectronics. The company was founded by Jonathan Klamkin and Lee McCarthy on February 28, 2019 and is headquartered in Goleta, CA.

Aeluma Inc

Aeluma is trending as investors await the upcoming earnings release, with discussion focused on the company's progress toward commercialization and the potential impact of its strategic photonics manufacturing agreements. Community sentiment remains divided between optimism over government-backed contracts and skepticism regarding the timeline for achieving meaningful commercial revenue.

Hub Cyber Security (Israel) Ltd. engages in the development of computer software and the establishment of quality and reliability systems. It operates through the following segments: Consulting, Software, Training, and Software Testing and Outsourcing. The Consulting segment provides engineering and management consulting services in the fields of management and establishment of quality and reliability systems, reliability and safety analyzes, improvement works of processes and products, risk analysis and management, writing procedures and analytical reports, certification of organizations and companies according to accepted standards. The Software segment engages in software development for calculating reliability and safety data, for collecting and reporting incidents and faults, as well as databases. The Training segment engages in trainings and certifications in the areas of quality, safety, reliability and as part of training for the IDF, in the fields of command, management, organizational behavior, and preparation for military service. The Software Testing and Outsourcing segment provides solutions and services in the fields of test engineering, formation and characterization of processes, establishment of test groups and laboratories, development of quality indices, implementation of test methodologies in accordance with the organization's strategy and placement of employees in the above fields. The company was founded by Zigmund Bluvband on June 13, 1984 and is headquartered in Tel Aviv, Israel.

Hub Cyber Security Ltd

Hub Cyber Security is trending following its recent 1-for-25 reverse stock split, which prompted intense debate among traders regarding the company's frequent reverse splits and ongoing dilution concerns. The community remains divided between speculative hopes for a short squeeze or turnaround and skepticism fueled by the stock's poor historical performance and the company's financial state.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals is trending primarily due to the positive topline results from its Phase 3 SHASTA-3 and SHASTA-4 clinical studies of plozasiran in patients with severe hypertriglyceridemia, which demonstrated significant reductions in triglycerides and acute pancreatitis events. The community reaction is largely bullish regarding the company's platform and the potential of plozasiran to become a best-in-class therapeutic, though discussions are also colored by frustration over perceived market manipulation and volatility.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is in focus as the Senate prepares for a procedural vote on the CLARITY Act, with traders debating whether potential passage would trigger a rally or if a failed vote is already priced in. Sentiment remains divided, as many investors weigh regulatory risks against institutional upgrades and Bitcoin's cyclical price action.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

Axon is experiencing significant volatility and a downward trend as traders react to a recent $1 billion convertible senior notes offering, leading to concerns regarding future shareholder dilution. Additionally, the conversation is marked by intense frustration from some investors over executive insider selling and persistent skepticism regarding the company's high valuation despite its growth projections.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CELC 🚨
Best R/R setup in biotech 
From 151 back to 80s
 Consolidating for over 2 Weeks
PDUFA in 1 Month
Runup to start soon
Void under key support levels

HR+/HER2- breast cancer is one of the largest solid tumor markets globally, and resistance to CDK4/6 plus endocrine therapy is a growing clinical problem, so even a modestly differentiated PAM-pathway inhibitor can support blockbuster-level peak sales if it establishes a foothold in later lines and then moves earlier @Pharmdca

https://x.com/TenetCharts

SDN_General

Baby Billy

J. Padilla

J. Hoffman

Sharing Chart Setups & Technical Analysis for Stocks & Futures for Trading & Investment Proprietary @ripster47 Charts , Part of @tenettradegroup NFA

TENET CHARTS (@TenetCharts) on X

$CELC Spike 🤔🚀
While huge winner already  but some insane volume
Scale out before binary 
Scale out before binary already and big part of our biotech portfolio ,small risk into PDUFA now
👇👇

StockTwits for iOS

Ripster , Tenet Trade Group

$CELC $CELC 💡
Home Run Gap Fill setup
Gave this setup in 83/85
Now 114
See before/after
Follow @TenetCharts for more such setup
Big winner for us in tenetresearch.ai

StockTwits For Android 

Celcuity Inc

 🚨
Best R/R setup in biotech 
From 151 back to 80s
 Consolidating for over 2 Weeks
PDUFA in 1 Month
Runup to start soon
Void under key support levels

HR+/HER2- breast cancer is one of the largest solid tumor markets globally, and resistance to CDK4/6 plus endocrine therapy is a growing clinical problem, so even a modestly differentiated PAM-pathway inhibitor can support blockbuster-level peak sales if it establishes a foothold in later lines and then moves earlier 

@ripster47 🤞From your post to God’s ear.